Vaccines, Journal Year: 2025, Volume and Issue: 13(5), P. 473 - 473
Published: April 28, 2025
With the successful deployment of several mRNA vaccines against SARS-CoV-2, an vaccine RSV (respiratory syncytial virus) and a large pipeline products other infectious diseases, cancers rare it is important to examine whole product lifecycle. technology enables design, testing manufacturing systems be rapidly developed, but these advantages can lost if factors that determine public access are not closely considered. This review analyzes key aspects lifecycle including candidate manufacturing, quality safety storage. Regulatory thinking well advanced in some countries others, more thought on regulation outside pandemic situation as therapeutics individual neoantigen therapies disease treatments needed. Consumer acceptance—the “social license operate” around products—is critical for their uptake, particularly pandemic.
Language: Английский